Ohio State University - CTMO Parent

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)2 trials

Phase

• Phase 22 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• EMD Serono Research & Development Institute, Inc.1 trial
• Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 trial

Running trials

• Active, not recruiting

  The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

  NCT05540327· Phase 2· Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany· Source

Closed trials

• Completed

  The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

  NCT05162586· Phase 2· EMD Serono Research & Development Institute, Inc.· Source